First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) vs combination chemotherapy (combo CT) in clinically aggressive HR+/HER2-advanced breast cancer (ABC): a subgroup analysis of RIGHT Choice by intrinsic subtype & gene & signature expression

Lu Y., Hsu C., Mahidin E. I. B. M., Gupta S., Goekmen E., Artamonova E., ...Daha Fazla

CLINICAL CANCER RESEARCH, cilt.31, sa.12, 2025 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 31 Sayı: 12
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1158/1557-3265.sabcs24-ps2-06
  • Dergi Adı: CLINICAL CANCER RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır